News Focus
News Focus
icon url

justdafactss

08/07/21 3:51 PM

#177829 RE: kgromax #177824

Ahh yes, title of PR gives the inclination P3 is granted a go-

CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients

But but but but right below the title it says-

Expects to Conduct Interim Analysis After Completion of 40% of the Enrollment

Then in the first paragraph admits-

has approved the previously submitted clinical trial protocol to commence patient enrollment in its CD17 trial for severe COVID-19 patients.
https://finance.yahoo.com/news/cytodyn-receives-clearance-brazil-anvisa-100000047.html

Title was enough to convince CYDY loyalists that ANVISA authorized injections.